crystalmaker highlight polyhedra withour central atom

The main reason why in silico methods are not capable to deliver is our poor understanding of the compound structure–thermodynamics and structure–kinetics correlations.

It is not yet possible to develop such compounds using computational (i.e., in silico) approach and instead the lead molecules are discovered in high-throughput screening searches of large compound libraries. This should enhance the development of chemical compounds that would specifically, selectively, reversibly, and with high affinity interact with a target protein. The aim of rational drug design is to develop small molecules using a quantitative approach to optimize affinity. This approach appears promising and it call consideration for the design of new therapeutic routes to cure patients affected by this disease. The obtained results appear very promising as the tumour growth was definitively markedly lower in comparison to controls and the CAIX inhibitor alone. After irradiation with thermal neutrons tumour growth was evaluated for 25 days by MRI. Next, an in vivo model was prepared by subcutaneous injection of AB22 cells in Balb/c mice and CA-SF was administered as inclusion complex with a β-cyclodextrin oligomer. The synergic cytotoxic effects operated by the enzymatic inhibition and neutron irradiation was evaluated in vitro on Z元4, AB22 and MCF7 cancer cells. This finding was exploited for the delivery of a therapeutic dose of boron (> 20 μg/g) to the cancer cells. The CAIX expression, measured by Western blot analysis, resulted high in both mesothelioma and breast tumours. This task was pursued by designing a sulfonamido-functionalised-carborane (CA-SF) that acts simultaneously as CAIX inhibitor and boron delivery agent. Simply click the 'Reload' button and all will be well with the world.This study aims at merging the therapeutic effects associated to the inhibition of Carbonic Anhydrase IX (CAIX), an essential enzyme overexpressed by cancer cells including mesothelioma and breast cancer, with those ones brought by the application of Boron Neutron Capture Therapy (BNCT). You do not have to restart your web browser or your computer after you enable JavaScript. Open your browser preferences, and enable JavaScript.

You need to turn JavaScript on in order to control this web page. Video Tutorials Learn about CrystalMaker in these detailed audio-visual tutorials

Crystalmaker highlight polyhedra withour central atom